EPKINLY

EPCORITAMAB-BYSP · Genmab US, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for EPKINLY, covering 2023-05-19 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]

See pricing